Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 700 (LINC00700) is a gene on human chromosome 10 that encodes a long non-coding RNA (lncRNA), meaning it does not produce a functional protein product. It is classified as an intergenic lncRNA and is catalogued in major gene and RNA databases, including Ensembl (ENSG00000234962), HGNC (HGNC:27422), and LNCipedia. LINC00700 has four described transcripts, is primarily non-conserved, and currently lacks experimental data linking it to specific biological functions or disease pathways. LINC00700 is characterized as a long non-coding RNA whose specific biological functions have not been clearly attributed in available evidence. General lncRNA roles include regulation of gene expression, RNA processing, and potentially chromatin modification, but LINC00700 has not been shown to have a specific function in these processes to date. There is no direct evidence from current search results linking LINC00700 to major diseases such as cancer, inflammation, neurodegenerative disease, or cardiovascular disease. LINC00700 may have altered copy number in some genomic studies but is not established as a driver in human disease. It is not recognized as a therapeutic target, nor are there any associated interacting drugs or safety considerations. No drugs are reported to interact directly with LINC00700 in current databases or literature. No known mechanism of action for drugs targeting this molecule exists. LINC00700 is not established as a clinical biomarker based on current evidence. No notable safety or therapeutic concerns are associated with LINC00700, as it is not a therapeutic target.
No known mechanism of action for drugs targeting this molecule exists.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 700 (LINC00700).